ANTISENSE-NUKLEINSÄUREN

European patent · EP3018211 · Deleted

Register entry

Publication number
EP3018211
Application number
EP15199455
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Aug 31, 2011
Published
May 11, 2016
Granted
Aug 7, 2019
Deleted
May 18, 2022
Reason
Revoked in opposition
IPC classes
C12N 15/113 (2010.01)
A61K 31/7125 (2006.01)
C12N 15/11 (2006.01)
Priority
JP 2010196032 01.09.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 18, 2022

    Change

    Published in Swissreg on 18.05.2022

  2. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

  3. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

  4. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

  5. Dec 10, 2019

    Agent entered

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel

    Published in Swissreg on 10.12.2019

  6. Aug 7, 2019

    Granted

    Published in Swissreg on 07.08.2019

Parties

Holder

NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY

National Center of Neurology and Psychiatry

1-1, Ogawa-Higashi-cho, 4-chome, Kodaira-shi Tokyo 187-8551, JP

NIPPON SHINYAKU CO., LTD.

Nippon Shinyaku Co., Ltd.

14, Kisshoin Nishinosho Monguchicho, Minami-ku, Kyoto-shi, Kyoto 601-8550, JP

Agent

Valipat S.A. c/o BOVARD SA Neuchâtel

Rue des Noyers 11, 2000 Neuchâtel

Inventor

TAKEDA, Shin'ichi

Kodaira-shi Tokyo 187-8551, JP

NAGATA, Tetsuya

Kodaira-shi Tokyo 187-8551, JP

SATOU, Youhei

Tsukuba-shi Ibaraki 305-0003, JP

WATANABE, Naoki

Tsukuba-shi Ibaraki 305-0003, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.